| Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology JA Ajani, TA D’Amico, DJ Bentrem, J Chao, C Corvera, P Das, ... Journal of the National Comprehensive Cancer Network 17 (7), 855-883, 2019 | 796 | 2019 |
| Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology JA Ajani, TA D’Amico, DJ Bentrem, J Chao, D Cooke, C Corvera, P Das, ... Journal of the National Comprehensive Cancer Network 20 (2), 167-192, 2022 | 704 | 2022 |
| Restoration of metabolic health by decreased consumption of branched‐chain amino acids NE Cummings, EM Williams, I Kasza, EN Konon, MD Schaid, BA Schmidt, ... The Journal of physiology 596 (4), 623-645, 2018 | 295 | 2018 |
| Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software photoshop and matlab KA Matkowskyj, D Schonfeld, RV Benya Journal of Histochemistry & Cytochemistry 48 (2), 303-311, 2000 | 188 | 2000 |
| Patient-derived cancer organoid cultures to predict sensitivity to chemotherapy and radiation CA Pasch, PF Favreau, AE Yueh, CP Babiarz, AA Gillette, JT Sharick, ... Clinical Cancer Research 25 (17), 5376-5387, 2019 | 173 | 2019 |
| Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures receptor number KA Matkowskyj, R Cox, RT Jensen, RV Benya Journal of Histochemistry & Cytochemistry 51 (2), 205-214, 2003 | 122 | 2003 |
| Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans RE Carroll, KA Matkowskyj, S Chakrabarti, TJ McDonald, RV Benya American Journal of Physiology-Gastrointestinal and Liver Physiology 276 (3 …, 1999 | 120 | 1999 |
| Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma YT Chung, KA Matkowskyj, H Li, H Bai, W Zhang, MS Tsao, J Liao, ... Modern pathology 25 (5), 758-766, 2012 | 119 | 2012 |
| Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model KA Matkowskyj, JA Marrero, RE Carroll, AV Danilkovich, RM Green, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 277 (2 …, 1999 | 118 | 1999 |
| Mouse Model of Enteropathogenic Escherichia coli Infection SD Savkovic, J Villanueva, JR Turner, KA Matkowskyj, G Hecht Infection and immunity 73 (2), 1161-1170, 2005 | 117 | 2005 |
| Dextran sulfate sodium-induced murine colitis activates NF-κB and increases galanin-1 receptor expression JA Marrero, KA Matkowskyj, K Yung, G Hecht, RV Benya American Journal of Physiology-Gastrointestinal and Liver Physiology 278 (5 …, 2000 | 111 | 2000 |
| Versican-derived matrikines regulate Batf3–dendritic cell differentiation and promote T cell infiltration in colorectal cancer C Hope, PB Emmerich, A Papadas, A Pagenkopf, KA Matkowskyj, ... The Journal of Immunology 199 (5), 1933-1941, 2017 | 99 | 2017 |
| Metabolic heterogeneity in patient tumor-derived organoids by primary site and drug treatment JT Sharick, CM Walsh, CM Sprackling, CA Pasch, DL Pham, K Esbona, ... Frontiers in oncology 10, 529045, 2020 | 91 | 2020 |
| Pathogenic Escherichia coli increase Cl– secretion from intestinal epithelia by upregulating galanin-1 receptor expression G Hecht, JA Marrero, A Danilkovich, KA Matkowskyj, SD Savkovic, ... The Journal of clinical investigation 104 (3), 253-262, 1999 | 89 | 1999 |
| Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology KA Matkowskyj, ZE Chen, MS Rao, GY Yang Archives of pathology & laboratory medicine 137 (3), 338-350, 2013 | 85 | 2013 |
| Precision medicine in colorectal cancer: the molecular profile alters treatment strategies NH Tran, LL Cavalcante, SJ Lubner, DL Mulkerin, NK LoConte, L Clipson, ... Therapeutic advances in medical oncology 7 (5), 252-262, 2015 | 82 | 2015 |
| Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (panin) by capsaicin in lsl-kras g12d/pdx1-cre mice H Bai, H Li, W Zhang, KA Matkowskyj, J Liao, SK Srivastava, GY Yang Carcinogenesis 32 (11), 1689-1696, 2011 | 80 | 2011 |
| Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology JA Ajani, TA D’Amico, DJ Bentrem, D Cooke, C Corvera, P Das, ... Journal of the National Comprehensive Cancer Network 21 (4), 393-422, 2023 | 75 | 2023 |
| Galanin-1 receptor up-regulation mediates the excess colonic fluid production caused by infection with enteric pathogens KA Matkowskyj, A Danilkovich, J Marrero, SD Savkovic, G Hecht, ... Nature medicine 6 (9), 1048-1051, 2000 | 72 | 2000 |
| PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors SN Payne, ME Maher, NH Tran, DR Van De Hey, TM Foley, AE Yueh, ... Oncogenesis 4 (10), e169-e169, 2015 | 67 | 2015 |
